Safari Flower Company, a Wholly Owned Subsidiary of Aurora Cannabis, Receives EU-GMP Certification at Niagara Facility
StockNews.AIJul 23, 7:05 AM EDT1 source
Trading thesisImportance 8/10
ACB could see a near-term bullish move on EU-GMP milestone, with longer-term upside from expanded European medical cannabis exports.
AI summary
What happened and why it matters
Safari Flower Company, a wholly owned Aurora Cannabis subsidiary, received EU-GMP certification for its Ontario facility, valid for three years and boosting international medical cannabis export capacity. The April 2026 acquisition adds EU-GMP capacity to Aurora's global network, enabling supply to Germany, Poland, and the UK as regulated European demand grows.
EU-GMP certification granted for Safari's Ontario facility, three-year term.
Safari Flower Co. 59,000 sq ft cultivation/manufacturing site in Niagara Region.
Aurora acquired Safari in April 2026 to enhance EU capacity.
Potential revenue upside from supplying Germany, Poland, and the UK.
Sentiment rationale
EU-GMP certification expands Aurora's export-ready capacity to Europe, a key growth vector, potentially lifting sentiment and modestly lifting valuation over a 6–12 month horizon.
Certification valid for three years, boosting capacity for international medical cannabis markets.
03
Aurora acquired Safari in April 2026 to add EU-GMP capacity.
04
Target markets include Germany, Poland, and the UK.
Corporate Developments
Category: Corporate Developments. The article combines a regulatory milestone with a strategic acquisition, underscoring Aurora's push to scale EU-capable medical cannabis manufacturing.